Back | Next |
home / stock / ccxi / ccxi message board
Subject | By | Source | When |
---|---|---|---|
40.54 | crudeoil24 | investorshub | 10/08/2021 6:37:52 PM |
LOL, Missed the big pop, and wasnt really | Mikey | investorshub | 10/08/2021 6:26:36 PM |
THIS $LOW FLOAT > STAIRWAY TO HEAVEN! | crudeoil24 | investorshub | 10/08/2021 6:22:40 PM |
38.17 > hod | crudeoil24 | investorshub | 10/08/2021 6:10:03 PM |
whytestocks: $CCXI News Article - ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotec | whytestocks | investorshangout | 10/08/2021 5:25:48 PM |
$100+ price target!$$$ | Jess070283 | investorshub | 10/08/2021 3:49:47 PM |
Lol, don't say that ?? | mikebennett16 | investorshub | 10/08/2021 3:29:42 PM |
whytestocks: $CCXI News Article - CCXI Stock: The Big FDA News That Has ChemoCentryx Shares Skyrocke | whytestocks | investorshangout | 10/08/2021 3:15:47 PM |
Probably gonna be an offering after hours | rynlrt | investorshub | 10/08/2021 1:41:40 PM |
Lol. Got me 1200 shares of this beauty | pepeoil | investorshub | 10/08/2021 1:25:49 PM |
Chee chee chee home run here boys | pepeoil | investorshub | 10/08/2021 1:22:42 PM |
53M trading float! | crudeoil24 | investorshub | 10/08/2021 1:16:51 PM |
MASSIVE NEWS > WHAT A $WEET RUNNNNN! | crudeoil24 | investorshub | 10/08/2021 12:13:47 PM |
Time to make bank today boys, toooooo daaaaaa mooooooon | pepeoil | investorshub | 10/08/2021 12:07:32 PM |
Well played boys and girls, a glorious day! | Limey42 | investorshub | 10/08/2021 12:05:12 PM |
Just re-allocated from $AMC to here! Japan approving | newdmontheblock | investorshub | 09/27/2021 6:07:35 PM |
whytestocks: $CCXI News Article - ChemoCentryx Announces Approval in Japan of TAVNEOS(TM) (Avacopan) | whytestocks | investorshangout | 09/27/2021 4:25:54 PM |
Great news today....now it's up to the FDA | Limey42 | investorshub | 09/27/2021 3:12:07 PM |
Anything that sends us north is fine by | newdmontheblock | investorshub | 07/04/2021 2:37:29 PM |
I'm thinking we probably get a CONDITIONAL APPROVAL!! | chance4 | investorshub | 07/04/2021 1:19:48 PM |
News, Short Squeeze, Breakout and More Instantly...
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX PR Newswire TAVNEOS ® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif. , Oct. 20, ...
-- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS ® (avacopan) for patients with ANCA-associated vasculitis; additional poster will cover expression of kidney C5aR -- SAN CARLOS, Calif., Oct. 17,...
-- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and preclinical evidence from murine model -- SAN CARLOS, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), tod...